Sterigenics International announced that Michael B. Petras, Jr. has been appointed Chief Executive Officer (CEO), effective June 20, 2016. Petras has more than twenty-five years of leadership experience, most recently serving as President of Cardinal Health's Post-Acute Solutions businesses. Petras succeeds Michael Mulhern, who has been appointed to serve as Executive Chairman of the Sterigenics Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.46 USD | +2.50% | +2.32% | -31.99% |
05-31 | Sotera Health Unit Closes $2.26 Billion of Financing | MT |
05-21 | Piper Sandler Initiates Sotera Health at Neutral Rating With $13 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.99% | 3.24B | |
+22.91% | 87.14B | |
-23.75% | 75.59B | |
+0.85% | 26.78B | |
+4.10% | 17.89B | |
-14.20% | 16.44B | |
+2.34% | 15.68B | |
+76.91% | 13.06B | |
+72.91% | 13.3B | |
+38.99% | 12.77B |
- Stock Market
- Equities
- SHC Stock
- News Sotera Health Company
- Sterigenics International, Inc. Announces Executive Changes